Can a CT-Free navigation system pinpoint lung nodules with precision?

NCT ID NCT07743775

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study is testing whether a CT-free electromagnetic navigation system can accurately locate small lung nodules before surgery, compared to the standard CT-guided method. The goal is to see if the new approach can mark nodules within 10 millimeters of their center, which is crucial for successful removal. Researchers will also compare procedure time, complications, and recovery. The study involves adults with non-palpable pulmonary nodules who need sublobar resection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CT-Free electromagnetic navigation percutaneous localization system
What this could lead to
If successful, this could offer a safer, faster, and more accurate way to mark lung nodules before surgery, potentially reducing the need for repeated CT scans and improving surgical outcomes.
What could go wrong
This is an observational study, so it cannot prove cause and effect. The new method may not be as accurate or safe as standard CT-guided localization, and results may vary across different centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY-STAGE LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm Multiple Pulmonary Nodules

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nantong First People's Hospital

    Nantong, Jiangsu, China

  • Nantong Sixth People's Hospital

    Nantong, Jiangsu, China

  • Nantong University Affiliated Hospital

    Nantong, Jiangsu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.